What is the usual dosing of Steglatro for diabetes patients with kidney disease?

According to approved prescribing guidelines, Steglatro is not recommended for people with moderate to severe kidney disease (eGFR below 45 mL/min/1.73 m²) due to reduced effectiveness.

Overview

Patients with diabetes and kidney disease often face complex treatment choices. Steglatro (ertugliflozin) is a medication that may be part of diabetes care for some, but its use depends on kidney function.

• Steglatro dosing is affected by kidney function levels.
• There are specific eGFR thresholds for initiating or continuing treatment.
• This article provides a brief overview of how Steglatro works, who should use it, and current safety guidelines.

Next, we’ll look at how Steglatro functions in the body.

Detailed Information

How it works

Steglatro is a sodium-glucose co-transporter 2 (SGLT2) inhibitor.

It may help lower blood sugar by increasing glucose excretion through urine. The medication only works effectively when the kidneys have adequate function to filter glucose.

This helps explain why kidney health must be evaluated before and during treatment.

Clinical applications

Steglatro is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.

However, according to the prescribing information for Steglatro, its effectiveness drops significantly in patients with moderate or severe kidney impairment, and it’s generally not recommended if eGFR falls below 45.

Safety and Effectiveness

Safety profile

According to official Israeli health records, patients using Steglatro should be monitored regularly for kidney function. Potential side effects include urinary tract infections, dehydration, and increased urination.

Patients with underlying kidney disease may be more susceptible to adverse effects and reduced treatment benefits.

FDA approval and indications

Steglatro has been approved for managing type 2 diabetes in adults with sufficient kidney function. It is not indicated for patients with type 1 diabetes or diabetic ketoacidosis.

This makes it important to obtain the drug safely and only under a provider’s guidance.

Access and Availability

How to obtain safely

IsraelPharm offers international shipping of Steglatro to patients with a valid prescription. It’s important to work with a healthcare provider to determine if it’s appropriate for your condition—especially if you have kidney disease.

Key Takeaways

• Steglatro is used for type 2 diabetes, but its use depends heavily on kidney function.
• It’s not recommended for patients with an eGFR below 45 mL/min/1.73 m².
• Kidney function should be monitored regularly during treatment.
• Side effects can include frequent urination, dehydration, and urinary tract infections.
• Only start or continue Steglatro under medical supervision.

FAQ

Can I take Steglatro if my kidney function is mildly reduced?

Steglatro may be used for type 2 diabetes if your eGFR is above 45, but you’ll need close kidney monitoring. Ask your provider about safe options based on your test results.

What is the typical starting dose of Steglatro?

According to the IsraelPharm health blog, the typical starting dose is 5 mg once daily, which may be increased to 15 mg if tolerated and needed—but only if kidney function allows.

Why does kidney function matter for Steglatro?

Steglatro works through the kidneys to help remove glucose from the body. It becomes less effective—and potentially riskier—as kidney function declines.

Are there alternatives to Steglatro for people with reduced kidney function?

Yes, some diabetes medications are safer for people with advanced kidney disease. Your doctor can recommend a suitable medication based on lab results and overall health.

How much does Steglatro cost through IsraelPharm?

Prices may vary depending on dosage and supply. Visit IsraelPharm or contact customer service for personalized cost and shipping information.